Marshall Gerstein Joins MATTER as a Leading Sponsor
Marshall, Gerstein & Borun LLP is pleased to support MATTER, a community of leaders working together in a shared space to individually and collectively fuel the future of healthcare innovation.
MATTER and its supporters seek to proactively connect and promote collaboration among entrepreneurs, scientists, physicians and industry partners from a wide range of fields including medical devices, healthcare IT, diagnostics and biopharma. MATTER's initial strategic partners include many of the biggest names in the region's healthcare ecosystem, including technology, health providers and professional organizations.
MATTER members will have access to the mentor network, as well as workshops and events designed to inspire change, advance ideas in the healthcare-focused industry, and bring next-generation products and services to market.
“Marshall, Gerstein & Borun LLP has assisted entrepreneurial life sciences companies from startup to IPO, and supported companies during periods of growth through acquisition. Our professionals understand the importance of fostering the entrepreneurial vision and how to execute business goals,” said Heather Kissling, partner and chair of the biotechnology group. “The firm is enthusiastic about this opportunity to support next-generation healthcare technology companies.”
Marshall Gerstein focuses exclusively on intellectual property law, and protects, enforces, and transfers the intellectual property of clients, worldwide. The firm assists companies at all stages: not-for-profit technology to startup; not-for-profit to out-license; startup to acquisition; startup to collaboration; startup to industry giant; industry giant to spin-off; and collaborations. With backgrounds in mechanical, electrical, and chemical engineering and biotechnology, Marshall Gerstein's professionals collaborate to address complex technical and legal issues in an array of diverse industries including those related to biotechnology, chemical sciences, medical devices, nanotechnology, and pharmaceuticals.